Market revenue in 2023 | USD 1,806.2 million |
Market revenue in 2030 | USD 3,030.1 million |
Growth rate | 7.7% (CAGR from 2023 to 2030) |
Largest segment | Formulation development |
Fastest growing segment | Formulation Development |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Preformulation, Formulation Development |
Key market players worldwide | SGS, Intertek Group PLC, Recipharm, Lonza Group Ltd, Charles River Laboratories International Inc, Eurofins Scientific SE, Element Solutions Inc, Labcorp Holdings Inc, Thermo Fisher Scientific Inc, Catalent Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to formulation development outsourcing market will help companies and investors design strategic landscapes.
Formulation development was the largest segment with a revenue share of 76.81% in 2023. Horizon Databook has segmented the Germany formulation development outsourcing market based on preformulation, formulation development covering the revenue growth of each sub-segment from 2018 to 2030.
Germany is one of the top destinations worldwide for life science research activities owing to a large number of senior scientists, postdocs, and Ph.D. students in the country. The country has an innovative, diverse, and broad research landscape due to the stable framework in R&D.
This makes the universities, educational institutions, and research centers in the country admit several international researchers. In addition, Germany accounts for nearly 4% of overall global clinical trial activity share in 2021, according to the data published by Clinical Trials Arena (Verdict Media Limited).
Out of which, over 87% of trials in the country are industry-sponsored, with oncology as the leading therapeutic area of research. Several medium-sized pharmaceutical companies in the country significantly outsource drug pre-formulation and formulation development processes to key players in the market, contributing to the market share.
Horizon Databook provides a detailed overview of country-level data and insights on the Germany formulation development outsourcing market , including forecasts for subscribers. This country databook contains high-level insights into Germany formulation development outsourcing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account